Nested Therapeutics to Present Preclinical Data for NST-628, a Novel Pan-RAF/MEK Molecular Glue, in the New Drugs on the Horizon Series at 2024 AACR Annual Meeting

/PRNewswire/ -- Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,San Diego ,California ,United States ,San Diego Convention Center ,American ,Klaus Hoeflich ,American Association For Cancer Research ,Nested Therapeutics ,American Association ,Cancer Research ,Annual Meeting ,Fully Brain Penetrant ,Molecular Glue ,New Drugs ,San Diego Convention ,Nested Therapeutics Inc ,